153 related articles for article (PubMed ID: 26847798)
21. Detection of mucopolysaccharidosis III-A (Sanfilippo Syndrome-A) in dried blood spots (DBS) by tandem mass spectrometry.
Yi F; Hong X; Kumar AB; Zong C; Boons GJ; Scott CR; Turecek F; Robinson BH; Gelb MH
Mol Genet Metab; 2018 Sep; 125(1-2):59-63. PubMed ID: 30006231
[TBL] [Abstract][Full Text] [Related]
22. Analytical method for the determination of disaccharides derived from keratan, heparan, and dermatan sulfates in human serum and plasma by high-performance liquid chromatography/turbo ionspray ionization tandem mass spectrometry.
Oguma T; Tomatsu S; Montano AM; Okazaki O
Anal Biochem; 2007 Sep; 368(1):79-86. PubMed ID: 17603992
[TBL] [Abstract][Full Text] [Related]
23. A prospective one-year natural history study of mucopolysaccharidosis types IIIA and IIIB: Implications for clinical trial design.
Truxal KV; Fu H; McCarty DM; McNally KA; Kunkler KL; Zumberge NA; Martin L; Aylward SC; Alfano LN; Berry KM; Lowes LP; Corridore M; McKee C; McBride KL; Flanigan KM
Mol Genet Metab; 2016 Nov; 119(3):239-248. PubMed ID: 27590925
[TBL] [Abstract][Full Text] [Related]
24. The combined use of enzyme activity and metabolite assays as a strategy for newborn screening of mucopolysaccharidosis type I.
Polo G; Gueraldi D; Giuliani A; Rubert L; Cazzorla C; Salviati L; Marzollo A; Biffi A; Burlina AP; Burlina AB
Clin Chem Lab Med; 2020 Nov; 58(12):2063-2072. PubMed ID: 32432561
[TBL] [Abstract][Full Text] [Related]
25. High-Throughput Liquid Chromatography-Tandem Mass Spectrometry Quantification of Glycosaminoglycans as Biomarkers of Mucopolysaccharidosis II.
Wang J; Bhalla A; Ullman JC; Fang M; Ravi R; Arguello A; Thomsen E; Tsogtbaatar B; Guo JL; Skuja LL; Dugas JC; Davis SS; Poda SB; Gunasekaran K; Costanzo S; Sweeney ZK; Henry AG; Harris JM; Henne KR; Astarita G
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751752
[TBL] [Abstract][Full Text] [Related]
26. Analysis of glycosaminoglycans in cerebrospinal fluid from patients with mucopolysaccharidoses by isotope-dilution ultra-performance liquid chromatography-tandem mass spectrometry.
Zhang H; Young SP; Auray-Blais C; Orchard PJ; Tolar J; Millington DS
Clin Chem; 2011 Jul; 57(7):1005-12. PubMed ID: 21576268
[TBL] [Abstract][Full Text] [Related]
27. Incomplete biomarker response in mucopolysaccharidosis type I after successful hematopoietic cell transplantation.
Kuiper GA; van Hasselt PM; Boelens JJ; Wijburg FA; Langereis EJ
Mol Genet Metab; 2017 Sep; 122(1-2):86-91. PubMed ID: 28684085
[TBL] [Abstract][Full Text] [Related]
28. A novel liquid chromatography/tandem mass spectrometry method for the quantification of glycine as biomarker in brain microdialysis and cerebrospinal fluid samples within 5min.
Voehringer P; Fuertig R; Ferger B
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Nov; 939():92-7. PubMed ID: 24121745
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and mass spectrometric analysis of disaccharides from methanolysis of heparan sulfate.
He QQ; Trim PJ; Snel MF; Hopwood JJ; Ferro V
Org Biomol Chem; 2018 Nov; 16(45):8791-8803. PubMed ID: 30403218
[TBL] [Abstract][Full Text] [Related]
30. Determination of urinary oligosaccharides by high-performance liquid chromatography/electrospray ionization-tandem mass spectrometry: Application to Hunter syndrome.
Nielsen TC; Rozek T; Hopwood JJ; Fuller M
Anal Biochem; 2010 Jul; 402(2):113-20. PubMed ID: 20382108
[TBL] [Abstract][Full Text] [Related]
31. Chemically modified recombinant human sulfamidase (SOBI003) in mucopolysaccharidosis IIIA patients: Results from an open, non-controlled, multicenter study.
Harmatz P; Muenzer J; Ezgü F; Dalén P; Huledal G; Lindqvist D; Gelius SS; Wikén M; Önnestam K; Bröijersén A
Mol Genet Metab; 2022 Aug; 136(4):249-259. PubMed ID: 35835061
[TBL] [Abstract][Full Text] [Related]
32. Validation of an LC-MS/MS assay for detecting relevant disaccharides from keratan sulfate as a biomarker for Morquio A syndrome.
Martell LA; Cunico RL; Ohh J; Fulkerson W; Furneaux R; Foehr ED
Bioanalysis; 2011 Aug; 3(16):1855-66. PubMed ID: 21877895
[TBL] [Abstract][Full Text] [Related]
33. Validation of keratan sulfate level in mucopolysaccharidosis type IVA by liquid chromatography-tandem mass spectrometry.
Tomatsu S; Montaño AM; Oguma T; Dung VC; Oikawa H; de Carvalho TG; Gutiérrez ML; Yamaguchi S; Suzuki Y; Fukushi M; Kida K; Kubota M; Barrera L; Orii T
J Inherit Metab Dis; 2010 Dec; 33 Suppl 3():S35-42. PubMed ID: 20107903
[TBL] [Abstract][Full Text] [Related]
34. Bioanalytical method development and validation for the determination of glycine in human cerebrospinal fluid by ion-pair reversed-phase liquid chromatography-tandem mass spectrometry.
Jiang J; James CA; Wong P
J Pharm Biomed Anal; 2016 Sep; 128():132-140. PubMed ID: 27262106
[TBL] [Abstract][Full Text] [Related]
35. Increased Alveolar Heparan Sulphate and Reduced Pulmonary Surfactant Amount and Function in the Mucopolysaccharidosis IIIA Mouse.
Paget TL; Parkinson-Lawrence EJ; Trim PJ; Autilio C; Panchal MH; Koster G; Echaide M; Snel MF; Postle AD; Morrison JL; Pérez-Gil J; Orgeig S
Cells; 2021 Apr; 10(4):. PubMed ID: 33918094
[TBL] [Abstract][Full Text] [Related]
36. Intravenous delivery of a chemically modified sulfamidase efficiently reduces heparan sulfate storage and brain pathology in mucopolysaccharidosis IIIA mice.
Gustavsson S; Ohlin Sjöström E; Tjernberg A; Janson J; Westermark U; Andersson T; Makower Å; Arnelöf E; Andersson G; Svartengren J; Ekholm C; Svensson Gelius S
Mol Genet Metab Rep; 2019 Dec; 21():100510. PubMed ID: 31528541
[TBL] [Abstract][Full Text] [Related]
37. Liquid-liquid extraction of strongly protein bound BMS-299897 from human plasma and cerebrospinal fluid, followed by high-performance liquid chromatography/tandem mass spectrometry.
Xue YJ; Pursley J; Arnold M
J Pharm Biomed Anal; 2007 Apr; 43(5):1728-36. PubMed ID: 17204392
[TBL] [Abstract][Full Text] [Related]
38. Quantitative analysis of amyloid beta peptides in cerebrospinal fluid of Alzheimer's disease patients by immunoaffinity purification and stable isotope dilution liquid chromatography/negative electrospray ionization tandem mass spectrometry.
Oe T; Ackermann BL; Inoue K; Berna MJ; Garner CO; Gelfanova V; Dean RA; Siemers ER; Holtzman DM; Farlow MR; Blair IA
Rapid Commun Mass Spectrom; 2006; 20(24):3723-35. PubMed ID: 17117458
[TBL] [Abstract][Full Text] [Related]
39. Low-dose, continuous enzyme replacement therapy ameliorates brain pathology in the neurodegenerative lysosomal disorder mucopolysaccharidosis type IIIA.
King B; Hassiotis S; Rozaklis T; Beard H; Trim PJ; Snel MF; Hopwood JJ; Hemsley KM
J Neurochem; 2016 May; 137(3):409-22. PubMed ID: 26762778
[TBL] [Abstract][Full Text] [Related]
40. Development and validation of a serum total testosterone liquid chromatography-tandem mass spectrometry (LC-MS/MS) assay calibrated to NIST SRM 971.
French D
Clin Chim Acta; 2013 Jan; 415():109-17. PubMed ID: 23085208
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
